ArticleInternational journal of clinical oncology2024

Pembrolizumab in Japanese patients with primary mediastinal large B-cell lymphoma: results from the KEYNOTE-A33 study.

Koji Kato et al.PubMed ↗Publisher ↗

No numbers read from the abstract.